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9. Crusting in the Trachea
This is fairly common and usually results from inade-
quate humidification. It is treated by removal of the crusts,
adequate humidification and instillation of drops of 4%
bicarbonate down the trachea to loosen the crusts.
10. Tissue Necrosis
Necrosis may follow wound sepsis or pre-operative
radiotherapy. As a result of tissue necrosis, sinuses and
fistulae may form which may require closure with plastic
surgery.
11. Local Recurrence
This is treated radically with deep X-ray therapy.
ASSESSMENT OF RESULTS
During the period January 1961-April 1965, 50 patients
were subjected to laryngectomy at Groote Sehuur Hospital.
Thirty-five operations were done for intrinsic carcinoma
TABLE IV. CASES SUBJECTED TO LARYNGECTOMY 1961-APRIL 1965
Year White Coloured Bantll Total
1961 3 I 0 4
1962 7 2 2 11
1963 7 2 2 11
1964 13 2 0 15
1965 3 5 1 9
Total 33 12 5 50
Percent 66 24 10 100
TABLE V. LARYNGECTOMY IN CASES Of INTRINSIC CANCER Of THE
LARYNX
Year Total no. ofcases Alive Dead Unknown
1961 3 2 0 1
1962 9 5 3 1
1963 10 7 1 2
1964 10 10 0 0
1965 3 2 0 1
Total 35 26 4 5
and 13 operations for extrinsic laryngeal cancer. There
were 2 cases which could not be classified. The 35 cases of
intrinsic carcinoma included 9 supraglottic, 24 glottic and
2 subglottic lesions.
We do not believe that one can draw any conclusions
from these cases, as the survival period is too limited to
be of any real value. Twenty-six patients are known to be
alive, 4 have died and 5 patients could not be traced. It is
of interest to note that in 35 laryngectomies, 12 cases had
pre-operative radiotherapy and 12 cases experienced de-
layed healing as judged by fistulae formation. Eight of the
patients with delayed healing had received pre-operative
radiotherapy.
Figures can be very misleading but it may be interesting
to refer to some of the results quoted by Work and Boyle
on cancer of the larynx published in the Laryngoscope of
July 1961: they treated 13 cases of carcinoma with X-ray
therapy alone with a 76% 5-year survival; 18 cases of
supraglottic carcinoma were treated in a similar manner
with an II % 5-year cure rate. In 14 cases of cordal carci-
noma treated with X-ray therapy followed by surgery, the
5-year cure rate was approximately 64%, and with 5 cases
of supraglottic carcinoma it was approximately 40%. In 41
cases of cordal carcinoma treated by surgery there was a
70% 5-year survival rate, while 25 cases of supraglottic
carcinoma treated surgically gave approximately 56% 5-
year cure rate.
They feel that the policy of 'watchful waiting' for cer-
vical lymph node metastases to occur following laryngec-
tomy has been discouraging even if block dissection is per-
formed later. If block dissection is done in continuity with
laryngectomy in these patients the survival rate could be
improved.
SUMMARY
The place that laryngectomy should take in the treatment of
intrinsic carcinoma of the larynx is discussed. Thirty-five cases
treated in this manner are recorded and the management de-
scribed.
I wish to thank Dr. J. G. Burger, Medical Superintendent of
Groote Sehuur Hospital and Dr. W. Dickie Clark, Head of
the Department of Otorhinolaryngology, for allowing this
article to be published. I should also like to thank Dr. J. F.
Jarvis for useful comments, and Dr. J. Jacobson of the De-
partment of Anaesthetics, for contributing an interesting para-
graph on the anaesthesia used in laryngectomy.
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FURTHER DEVELOPMENTS IN THE TREATMENT OF POISONING WITH
ALKYLPHOSPHATE (ORGANOPHOSPHATE) INSECTICIDES
Douw G. STEYN, Poisons Commillee, State Department of Health, Pretoria
In 1958 I reviewed the then existing methods of treatment
of alkylphosphate poisoning.'-' In this paper, I shall dis-
cuss the more recent knowledge we have gained as to the
symptoms caused by, and the mechanisms and modes of
action of, different alkylphosphate insecticides, as well as
the more successful methods of treatment of cases of
poisoning. It is a great step forward in the treatment of
cases of alkylphosphate poisoning that a reactivator
(Toxogonin) of the inactivated ChE (cholinesterase) which
passes the blood-brain barrier, has been discovered. Not
only does Toxogonin pass the blood-brain barrier but,
according to reports in the literature, it is also more effec-
tive in cases of poisoning with some organophosphates,
and is less toxic than PoAM which does not pass the blood-
brain barrier, or does so only to a very limited extent.
SYMPTOMS OF ORGANOPHOSPHATE POISONING
It is clear that the symptoms of poisoning with organo-
phosphates are due not only to inactivation of cholineste-
rase (ChE), i.e. cholinergic, but that other factors also have
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to be considered as will be gathered from the evidence
presented below. It appears obvious that alkylphosphates
will affect not only CbE but also other enzyme systems. It
is therefore not surprising that reactivators (P,AM, P,S,
DAM, MINA) of CbE inactivated by organophosphates
are not 100% effective in all cases of poisoning with these
insecticides. Further, the actions of organophosphates
depend upon the nature of the phosphate and on the
species. They can cause death by virtue of their central or
peripheral action, or both.
According to Hegazy' and various other investigators,
organophosphate compounds interfere not only with ChE
but also with the action of many other enzyme systems,
hence 'the poisonous action of organic phosphate com-
pounds could not be explained solely as an inhibition of
cholinesterases, and neurological disturbances in patients
poisoned by organophosphorus compounds were the result
of the stimulant action of organic phosphates on sympa-
thetic ganglia and cerebral centres'.
Hegazy' described meta-isosystox poisoning in 126 men
employed as sprayers of insecticides and in accidentally-
exposed patients. He states: 'Serum cholinesterase levels
showed an initial fall and then a rise above normal. The
fall of cholinesterase was marked in patients who were
exposed for relatively long periods but not in patients
accidentally exposed for short times. The rise in serum
cholinesterase is thought to be a compensatory protective
mechanism.
'Correlation between serum cholinesterase levels and
symptomatology was absent in some patients but present
in the majority. Cholinesterase inhibition may not be the
only mechanism by which organic phosphorus compounds
cause poisoning.'
Hobbiger4 states that it is widely believed 'that organo-
phosphates possess other actions in addition to those
mediated by cholinesterase inhibition. The results obtained
with 1 particular organophosphate are not applicable to
other organophosphates which form the same type of
phosphorylated enzyme.'
Hegazy' refers to observations made by Hayes and
others that 'some degree of tolerance may develop in per-
sons exposed to organic phosphorus compounds for long
periods'.
Studt and Wetzel' report 'a highly unusual toxic picture
with ulcerative stomatitis' in a suicide attempt with para-
thion. They state: 'This lesion has so far been almost
exclusively seen in fatal cases, but the patient in question
recovered. The manifestations are ascribed to "endogenous
acetylcholine poisoning" with "total autonomic derange-
ment" combined with a toxic-allergic process in the form
of a symptomatic thrombopenia.'
Enders and Grupp" found Heinz bodies in the red blood
cells of rats chronically poisoned with parathion; the
blood picture resembled that seen in nitrobenzol poisoning.
According to Hegazy,' serum CbE levels are low in cases
of malnutrition, liver disease and bilharziasis. Fluctuations
in serum CbE levels in the same individual may amount
to 10 - 15%. The above phenomena will render the indivi-
duals concerned more susceptible to organophosphate
poisoning and also stress the importance of the determina-
tion of serum CbE levels in all individuals who are likely
to be exposed to organophosphates. Special consideration
should be accorded individuals whose employment will
expose them to the effects of organophosphates.
Potentiation of the Toxicity of Insecticidal Organophos-
phates
An article published by Dubois' on potentiation of the
toxic effects of insecticidal organophosphates among
themselves and by other insecticides, by chemicals used in
food processing and accidentally contaminating food and
drink, and by drugs, is deserving of serious consideration
and extensive investigation in the interest of human and
animal health. There is ample evidence that various chemi-
cals (pesticides, chemicals used in food processing, and
drugs) may either have a potentiation or additive effect
or may, to a certain degree, counteract each other's harm-
ful effects on man and animal. The potentiation and/or
additive effects of chemical substances may be:
(a) the result of their synergistic pharmacologic or
toxicologic actioos; or
(b) may be due to the fact that the most important
organs of excretion Oiver, kidneys) are damaged
resulting in delayed excretion of the poison(s) con-
cerned; or
(c) may be due to the chemicals concerned inhibiting
or preventing each other's detoxification in the
body; or
(d) they may interact chemically in the body forming
compounds more (or less) toxic than the original
compounds.
An important point in the problem of potentiation or
additive effects of chemicals is the relative quantities
which enter the body.
Minimal quantities of pesticides and/ or other chemicals
present in articles of food may not potentiate each other's
harmful effects or have additive effects, while the ingestion
of larger quantities of these chemicals (subacute and acute
poisoning) may do so.
Distribution of Parathion in the Body of Exposed
Individuals
There is ample evidence that the concentrations of
parathion detectable in the various organs of victims of
parathion poisoning vary greatly.
In a fatal case of parathion poisoning in a 27-year-old
blacksmith, Schweitzer" reports that the brain contained
2t times the amount of parathion that was found in the
liver (per unit of weight).
Karlog and Poulsen9 studied the spontaneous and prali-
doxime (P,AM)-induced reactivation of brain ChE in the
chicken after fatal nitrostigmine (parathion) poisoning.
They found that after administration of parathion, brain
CbE activity was reduced to 10% immediately after death.
Two further points of importance emerged from the above
study made by Karlog and Poulsen, namely:
(I) after 8 days of storage normal controls showed a
decrease of 25% in CbE activity; and
(ii) during postmortem storage a gradual reactivation
of the inactivated CbE occurred up to the extent
of 50% of the normal. These findings are of great
importance as far as the collection of specimens for
CbE determinations is concerned.
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TREATMENT OF CASES OF ORGANOPHOSPHATE POISONING
The curative effects of mono-isonitrosoacetone (MINA) and
of diacetyl monoxime (DAM), pyridine aldoxime methiodide
W,AM) and other oximes in cases of organophosphate poison-
mg have been investigated.
Investigations conducted by Askew et al.'· have shown that
the therapeutic properties of the various oxirnes differ in
degree in their curative effects in cases of poisoning with
d~erent .organophosphates. These authors compared the che-
Illlcal, bIOchemical and therapeutic properties of MINA,
I?AM and P,AM and found a number of interesting anoma-
lies. They state: 'Thus, their relative therapeutic potencies are
not entirely consistent with their reactivities with organophos-
phates or with their reactivating powers. Whereas MINA and
P,AM react at about the same rate with organophosphates,
pAM reacts more slowly, while the reactivation powers fall
ill the order P,AM > MINA > DAM; yet DAM and MINA
are equally effective in animals poisoned with isopropyl
methylphosphonofluoridate (Savin) but P,AM is ineffective.'
Rosenberg and Coon" found that in rats poisoned with
~PN (ethyl-p-nitrophenyl-thionobenzene phosphonate) mortal-
Ity was reduced by the adm'inistration of nikethamide and
nicotinamide. They suggest that this beneficial effect was due
to the protection of tissue cholinesterase. This investigation by
Rosenberg and Coon was prompted by findings reported by
DiStefano and his co-workers, namely, that 'intraperitoneal
'injection of nikethamide plus atropine in female rats increased
the oral LD50 of simultaneously administered ethyl-p-nitro-
phenyl thionobenzene phosphonate (EPN) approximately 10
times, whereas atropine alone only doubled the LD",'.
In the course of a clinical evaluation of 24 cases of organo-
phosphate poisoning treated with atropine and pralidoxime,
Quinby12 found that the use of pral'idoxime ( = 2-pyridine
aldoxime methyliodide and 2-pyridine aldoxime methylchlo-
ride) was most valuable in parathion poisoning, but less so in
cases of phosdrin poisoning. Too few cases of tetraethyl pyro-
phosphate and malathion poisoning were treated to allow
reliable clinical evaluation; however, the results were promis-
ing. The side-effects induced by pralidoxime were minimal. 1%
Pralidoxime iod'ide may induce one or more of the follow-
ing symptoms: dizziness, blurred vision, diplopia, headache,
impaired accommodation, nausea, and tachycardia.
According to Erdmann and Von Clarmann,13 P,AM does
not pass the blood-brain barrier, with the result that the
cholinesterases in the brain remain inactivated jar days and
even jar weeks. According to a note prepared by a medical
panel," 'The rate of recovery of cholinesterase activity de-
pends on the compound which was responsible for the poison-
ing and may take 2 or 3 months'. Many authors have expres-
sed the view that prolonged inactivation of the brain cholin-
esterases have been responsible for the psychic disturbances
(parano'ld and depressive reactions) .exhibited by the patients
concerned.
It was therefore most desirable to find an antidote to
organophosphate poisoning which will pass the blood-brain
barrier, thus reactivating the blocked cholinesterases.
Erdmann and Von Clarmann13 found that in cases of E605
(parath'ion) poisoning, Toxogonin [LiiH6, dichloride of bis-
(4-hydroxyiminomethyl-pyridinium-(I)-methyl)-ether] in doses
of 250 mg. intravenously, (i) acts quicker and better than
P,AM, and (ii) is quite safe when administered to normal
individuals in doses which are effective in cases of E605
poisoning.
It is stated that Toxogonin passes the blood-brain barrier
and is a more active antidote as it is effective in smaller doses
than P,AM.
Views as to the distribution of pyridoxine-2-aldoxime me-
thiodide (P,AM) in the different organs and systems of the
human and animal bodies differ, and this fact prompted
Loomis" to conduct further investigations. He studied the dis-
tribution and excretion of methyl- 14C tagged P,AM in mice
and dogs. The results of this investigation showed that 'after
intravenous injection, P,AM penetrates readily into the river
and kidney of mice and into most soft tissues of the dog. No
isotope was found in the brain of the mice, and only trace
amounts of isotope were found in the brain of 1 dog. Isotope
is retained in the t'issues except for the brain after it has been
cleared from the blood'.
Loomis confirmed the finding that the combined use of atro-
pine and oxime treatment in anti<:holi~esterasC? po~soning
yields the best results. The explanatIOn IS that ill thIS case
atropine protects the central nervous system from effects of
the _ant'isterase.
Erdmann et al. l6 conducted tests on 12 male volunteers (20-
28 years old) and found that intramuscular injection of Toxo-
gonin was painless. The test subjects testified that 5-10 minutes
after injection of Toxogonin they experienced (a) a warm and
tense feeling in the face muscles and a decrease in movement
in the mimic face muscles; (b) a cold sensation, on inspiration,
in the nose-palatal region (like that caused by menthol). All
these symptoms disappeared 2 - 3 hours after the injection.
Each of the test individuals received 250 mg. of Toxogonin
intramuscularly. Twenty to thirty minutes after the 'illjection
a maximum blood level of approximately 6 p.g. / ml. was re-
corded. Six hours after the injection the blood level of Toxo-
gonin had dropped to 1-2 p.g./ml. Erdmann et al.'· state that
Toxogonin is approximately 3 times more active than P,AM
in organophosphate poisoning. The dose is approximately 3·0
mg. / kg. body-weight intramuscularly.
Kuga and Erdmann" investigated the action of Paraoxon on
the centres of respiration and of the vagus and the effect of
various antidotes. They found that 'the peripherally-acting
antidotes Pralidoxime or methylatropine have no protective or
therapeutic effects on the spastic paralysis of the respiratory
movements of the glottis. An excellent antidotal act'ion how-
ever was obtained with the central-acting substances Toxo-
gonin or atropine.'
Heilbron and TolagenlS tested the reactivating effects of
P,S, TMB-4 and Toxogonin [LiiH6, BH6 = bis (4-hydroxymi-
nomethyl-pyridinium (1)-methyl)-ether dichloride] on atropi-
nized mice in experimental Savin, Soman and Tabun poison-
ing and found that of these 3 compounds Toxogonin has by
far the most beneficial effects.
DISCUSSION
The following points are of importance as far as the
toxicology and treatment of poisoning with insecticidal
organophosphates are concerned:
1. Organophosphates do not only inhibit ChE but also
other enzyme systems, with the result that the symp-
tom-complex caused by them is not only cholinergic
in nature but covers a much wider range of symptoms.
2. Some cases of organophosphate poisoning may initially
show a drop in ChE serum levels and then a transitory
rise above normal. This is probably a compensatory
protective mechanism.
This phenomenon should be kept in mind when tak-
ing specimens of blood for ChE determinations. Speci-
mens from the same patient should be taken at regular
intervals.
3. Correlation between serum ChE levels and symptoma-
tology is absent in some patients, consequently the
symptom complex may vary greatly in cases of poison-
ing with organophosphates.
4. Blood serum ChE levels .may be low in cases of mal-
nutrition, liver disease and bilharziasis. Also, in the
same individual serum ChE levels may from time to
time fluctuate appreciably (10 - 15%). These 2 pheno-
mena should lead us to execute not only 1 but repeated
determinations of serum ChE levels at specified inter-
vals over specified periods before deciding on 'normal
levels'. This procedure is of the utmost importance in
all cases where individuals may, or will, be exposed to
organophosphates (appliers of insecticides, industrial
workers, etc.). In all cases, serum ChE determinations
should be made before employment.
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5. It is important to note that parathion, and possibly
also other organophosphates, pass the blood-brain
barrier, with the result that they accumulate in the
brain, thus reducing ChE levels to extremely low and
dangerous levels. What is of still greater importance is
that the valuable antidote P:AM apparently does not
pass the blood-brain barrier, thus permitting the toxic
organophosphates to exert their harmful effects on the
central nervous system for extended periods. The ChE
in the brain may be, and often is, inactivated to a
serious degree (up to 90%) and may remain blocked
for days and even weeks or months. The prolonged
inactivation of brain CbE is probably responsible for
the mental confusion and psychic disturbances often
exhibited by patients suffering from organophosphate
poisoning.
6. The same oxime varies in its capacity as a curative
agent in cases of poisoning with different organophos-
phates; hence the importance of (a) establishing the
most effective and safest antidote in the case of each
organophosphate; and (b) the screening of existing
and any newly-developed oximes in order to establish
which are the most effective and safest and which of
them has the broadest spectrum of activity.
7. In comparison with P,AM, Toxogonin, according to
the available literature, possesses 3 important advan-
tages as an antidote in organophosphate poisoning,
namely:
(a) it passes the blood-brain barrier thus reactivating
the seriously inactivated ChE in the brain;
(b) it acts more quickly; and
(c) it is safer and more effective.
8. Vandekar et al.'" assessed the hazards of acute poison-
ing by carbamates and organophosphates. They found
that carbamates are safer than organophosphates as
far as fatalities are concerned, and state that the early
warning symptoms in cases of carbamate poisoning
serve as a means of preventing deaths.
The whole trend in the development of safer pesticides
should be to determine (a) the safest (least toxic) and most
effective chemical in a given pest; and (b) to discard the
most toxic pesticides in favour of other effective and safer
chemicals. If these lines of action were adopted, we would
perhaps succeed in discovering and using the least toxic
organophosphates. In addition it may be possible to
replace some of the most toxic organophosphates by less
toxic and less dangerous carbamates.
In assessing the toxicity and dangers of pesticides, their
relative tendencies to accumulate and persist in the body
or cause serious irreversible damage to organs or systems
should receive serious consideration. Those pesticides
which are inclined to accumulate or concentrate in the
central nervous system (brain) should receive special
attention. Such poisons are parathion (and possibly other
organophosphates) and DDT (and possibly other chlori-
nated hydrocarbons). These poisons affect certain impor-
tant enzyme systems detrimentally and their presence and
persistence in the brain cannot but be at least partially
responsible for the mental confusion and psychotic
disturbances exhibited by the patients concerned.
TREATMENT
It should be stressed that the first t hour after organophos-
phate poisoning is of the utmost importance to the fate of
the patient, and the treatment suggested below should
therefore be instituted immediately, and in the order
stated.
A blood sample should be taken before administration
of a cholinesterase activator.
1. Immediate removal of the patient(s) from the source
of poisoning.
2. Immediate removal of contaminated clothing. Ex-
posed areas of the skin should be thorougWy washed with
soap and water and 3% sodium bicarbonate in water. If the
eyes are affected, they should be treated with a 3% sodium
bicarbonate solution in water and with analgesic drops
for the pain.
3. Atropine sulphate should be injected at the earliest
possible moment and before a specific cholinesterase re-
activator is given.
Von Clarmann'" suggested the following treatment with
atropine: In very serious cases of organophosphate poison-
ing 2 - 5 mg. should be administered by slow intrave-
nous injection (children 0-3 - 3·0 mg.). If necessary, repeat
the injections every 5 - 15 minutes until symptoms of
atropinization (mydriasis, dry mouth) appear. In less
serious cases, smaller doses of atropine could be given
intramuscularly or subcutaneously. In extremely serious
cases a total dose of 40 - 100 mg. of atropine sulphate
and more was administered within 24 - 48 hours.
It should be kept in mind that atropine competes with
acetylcholine and is effective only in treating those effects
referable to the central and muscarinic action of acetyl-
choline, but does not affect the nicotinic action.
Warning: Atropine should be used with the utmost
care in cyanotic patients.
Taylor et al." recommend that 10 mg. of metaraminol
(Aramine = m-hydroxyphenyl-1-amino-2 propanol-1-[ +]-
bitartrate) be given parenterally with atropine because:
(a) it has been shown that the side-effects of atropine
will be reduced or obviated and
(b) 'there is suggestive evidence that metaraminol en-
hances the antagonistic action of atropine against
acetylcholine accumulation'. Metaraminol is a long-
acting sympathomimetic pressor drug.
4. Reactivators of the inactivated (phosphorylated)
cholinesterase. According to our present knowledge con-
cerning the mode of action and distribution of reactivators
in the body, it would appear that the safest, most quick-
acting and most effective reactivator is Toxogonin. Its
great advantage over P,AM is that it passes the blood-
brain barrier.
Unfortunately, our knowledge and experience with
Toxogonin is at present very limited and it is suggested
that extensive investigations be conducted into its thera-
peutic action in all cases of poisoning with organophos-
phates.
Von Clarmann'· suggests 250 mg. of Toxogonin intra-
venously. As it is fairly quickly eliminated, administration
should be repeated after 1 - 2 hours. Children should
receive 4 - 8 mg.jkg. body-weight as a single dose intra-
venously.
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At present the most widely used activator is P,AM. com-
mencing, in serious cases, with 1 G intravenously. Unfor-
tunately, it does not pass the blood-brain barrier, and
consequently it has no, or only a negligible, effect on
inactivated brain ChE.
5. Gastric lavage should be carried out it the poison
had been taken by mouth. Small quantities of fluid should
be used repeatedly as large quantities of fluid wash the
poison through the pyloric sphincter into the intestinal
canal. In order to facilitate hydrolysis and detoxification
of the poison an aqueous solution of 0·5 - I ~~ sodium
bicarbonate could be used.
Von Clarmann'" advises stomach lavage with carbo
medicinalis as it adsorbs large amounts of organophos-
phates.
Symptomatic Treatmenr
(a) Respiralion. This mUSl be carefully watched and the
patient kept under constant supervision. If necessary, artificial
respiration should be instituted. Excessive mucus secretion
must be removed by endotracheal intubation or even tracheo-
t~my, if necessary. The patient must be kept 'in a lateral posi-
tion.
Oedema of the lungs should be treated with slrophantin, hy-
pertonic glucose, blood letting, mercury diuretics, posterior
pituitary extract, high glucocorticoid dosage and oxygen.'"
(b) Heart. Intracardial injections and massage if necessary.
(c) Spasms. Administer phenobarbitone, or Somnifen and
muscle relaxants. Von Clarmann'" suggests succinylcholine:
however, according to Durham and Hayes" its use is contra-
indicated. They state that morphine, theophylline, aminophyi-
line and succinylcholine should never be given and tranquil-
lizers only with the utmost caution. Phenothiazines tend te
potentiate the blockage of ChE. With morphine there is a risk
of respiratory failure.
Patients should be kept under careful observation for a few
days as relapses may occur after initial periods of improve-
ment.
SUMMARY
The more recent knowledge gained as to the symptoms in-
duced by, and the mechanisms and modes of action of dif-
ferent insecticidal organophosphates are discussed. Attention
is drawn to the advantages of the use of Toxogonin over those
of P,AM, the most important being that the former reacti-
vator of ChE passes the blood-brain barrier and P,AM does
not, or does so to only a very sl'ight degree.
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WORLD POPULATION-PROBLEMS AND SOLUTIONS*
P. P. WIUM, Presidelll, Border CoasTal Branch (M.A.S.A.), 1965
The most fascinating problem facing the world today is our
. tremendously increasing population and the battle to maintain
an adequate standard of living for all, with sufficient food and
a balance between birth and death rates.
General Considerations
Man has been on this earth for perhaps 2 million years. It
took most of this tiIne to produce a population of I billion,
which was achieved in 1850. It required only 75 years to reach
2 billion, the population in 1925. In 1962, 37 years later the
population was 3 billion and continuation of this trend, like
compound interest, will provide a 4th billion in another 15
years and a 5th in less than another 10 years. This means that
our present population of 3·3 billions will rise to 6·9 billions
by the year 2000 unless something is done about it.
This spectacular acceleration has been brought about by a
sharp decline in the death rate, coupled with a great increase in
the average length of life.
In early Egypt, Greece and Rome, around the beginning of
the Christian era, the life expectancy was about 30 years. By
1900, life expectancy in Europe and North America had
reached 45 - 50 years and today, it is in excess of 70.
Three factors have contributed to the decline in the death
rate. The first was the general improvement in standards of
living, due to technological advances and comparatively long
periods of peace, by reason of relatively powerful and stable
governments. Secondly, great stride~ were !Ilade in the puriJ:ica-
tion of water and foodstuffs and Improvmg personal hygIene
and assisting in the elimination of parasitic and infectious
diseases. The third major factor is, of course, to be found in
the great and growing contribution of modern medicine, en-
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hanced by the recent progress in chemotherapy, antibiotics and
the insecticides.
The significant gains have been a fall in infant mortality,
with a potentially greater number to mature and reproduce in
the future, and an increased life span. Throughout all this time,
fertility has remained at a relatively high level.
The decline in the death rate was most apparent in Europe
and in countries colonized by European stock. Since World
War H, its influence has made an enormous impact on others,
especially through United Nations' programmes emphasizing
economic development and improved health and social services.
Today, the birth rate in the less developed countries where
2/3 of the world population live, is about 40 per 1000 com-
pared with 15 - 25 per 1000 in the industrial countries.
The United States, Europe and Japan are growing relatively
slowly and will double their po,Pulation in 50 to 100 years with
a natural increase of about 1%. Latin America, the Far East,
Asia and Africa will double in 20 - 40 years with an increase
of 2 - 3% per annum. Latin America, the fastest-growing of all,
will increase from 200 million to 650 million by the year 2000,
closely followed by that of Africa. India's 460 million will in-
crease in 15 years by 187 mimon, which is more than the
total number of people at present in the United States of
America!
In South Africa the total population is more than 16 million,
made up of over 3 million whites, It million Coloureds, t
million Asiatics (of which 90% are South-African born) and 11
million Bantu.
According to Dean in Port Elizabeth, the neonatal death rate
among the urban Bantu, mainly due to gastroenteritis and
pneumonia, has decreased from 500 per 1,000 to 200 per 1,000
between 1950 and 1963, and this is the trend throughout South
